Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature

Sujin Choi; Kyung Taek Hong; Jung Yoon Choi; Hong Yul Ahn; Jae Sung Ko; Kyung Suk Suh; Sung Hye Park; Jung Eun Cheon; Hee Young Shin; Hyoung Jin Kang

doi:10.1097/MPH.0000000000002121

Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature

Sujin Choi, Kyung Taek Hong, Jung Yoon Choi, Hong Yul Ahn, Jae Sung Ko, Kyung Suk Suh, Sung Hye Park, Jung Eun Cheon, Hee Young Shin, Hyoung Jin Kang

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Posttransplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases with abnormal proliferation of lymphoid tissue and classical Hodgkin lymphoma (CHL) type PTLD is a very rare subtype. We describe a successfully diagnosed and treated CHL-PTLD stage IV pediatric patient, 8 years after liver transplantation. The patient was treated with standard CHL (Children's Cancer Group 5942 group 3) chemotherapy, rituximab and reduction of immunosuppressant. The patient remains in complete remission after 3 years with stable graft function. To our best knowledge, this is the first pediatric case report of a successfully treated stage IV CHL-PTLD after a liver transplant.

Original language	English
Pages (from-to)	E1015-E1019
Journal	Journal of Pediatric Hematology/Oncology
Volume	43
Issue number	7
DOIs	https://doi.org/10.1097/MPH.0000000000002121
State	Published - 1 Oct 2021

Bibliographical note

Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.

Keywords

Asia
classical HL type PTLD
liver transplant
pediatric

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/MPH.0000000000002121

Cite this

Choi, S., Hong, K. T., Choi, J. Y., Ahn, H. Y., Ko, J. S., Suh, K. S., Park, S. H., Cheon, J. E., Shin, H. Y., & Kang, H. J. (2021). Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature. Journal of Pediatric Hematology/Oncology, 43(7), E1015-E1019. https://doi.org/10.1097/MPH.0000000000002121

@article{3ba978f783d9495f8e4ebffd7539d5cb,

title = "Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature",

abstract = "Posttransplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases with abnormal proliferation of lymphoid tissue and classical Hodgkin lymphoma (CHL) type PTLD is a very rare subtype. We describe a successfully diagnosed and treated CHL-PTLD stage IV pediatric patient, 8 years after liver transplantation. The patient was treated with standard CHL (Children's Cancer Group 5942 group 3) chemotherapy, rituximab and reduction of immunosuppressant. The patient remains in complete remission after 3 years with stable graft function. To our best knowledge, this is the first pediatric case report of a successfully treated stage IV CHL-PTLD after a liver transplant.",

keywords = "Asia, classical HL type PTLD, liver transplant, pediatric",

author = "Sujin Choi and Hong, {Kyung Taek} and Choi, {Jung Yoon} and Ahn, {Hong Yul} and Ko, {Jae Sung} and Suh, {Kyung Suk} and Park, {Sung Hye} and Cheon, {Jung Eun} and Shin, {Hee Young} and Kang, {Hyoung Jin}",

year = "2021",

month = oct,

day = "1",

doi = "10.1097/MPH.0000000000002121",

language = "English",

volume = "43",

pages = "E1015--E1019",

journal = "Journal of Pediatric Hematology/Oncology",

issn = "1077-4114",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

Choi, S, Hong, KT , Choi, JY, Ahn, HY, Ko, JS , Suh, KS , Park, SH , Cheon, JE , Shin, HY & Kang, HJ 2021, 'Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature', Journal of Pediatric Hematology/Oncology, vol. 43, no. 7, pp. E1015-E1019. https://doi.org/10.1097/MPH.0000000000002121

Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature. / Choi, Sujin; Hong, Kyung Taek ; Choi, Jung Yoon et al.
In: Journal of Pediatric Hematology/Oncology, Vol. 43, No. 7, 01.10.2021, p. E1015-E1019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient

T2 - A Case Report and Review of the Literature

AU - Choi, Sujin

AU - Hong, Kyung Taek

AU - Choi, Jung Yoon

AU - Ahn, Hong Yul

AU - Ko, Jae Sung

AU - Suh, Kyung Suk

AU - Park, Sung Hye

AU - Cheon, Jung Eun

AU - Shin, Hee Young

AU - Kang, Hyoung Jin

PY - 2021/10/1

Y1 - 2021/10/1

N2 - Posttransplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases with abnormal proliferation of lymphoid tissue and classical Hodgkin lymphoma (CHL) type PTLD is a very rare subtype. We describe a successfully diagnosed and treated CHL-PTLD stage IV pediatric patient, 8 years after liver transplantation. The patient was treated with standard CHL (Children's Cancer Group 5942 group 3) chemotherapy, rituximab and reduction of immunosuppressant. The patient remains in complete remission after 3 years with stable graft function. To our best knowledge, this is the first pediatric case report of a successfully treated stage IV CHL-PTLD after a liver transplant.

AB - Posttransplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases with abnormal proliferation of lymphoid tissue and classical Hodgkin lymphoma (CHL) type PTLD is a very rare subtype. We describe a successfully diagnosed and treated CHL-PTLD stage IV pediatric patient, 8 years after liver transplantation. The patient was treated with standard CHL (Children's Cancer Group 5942 group 3) chemotherapy, rituximab and reduction of immunosuppressant. The patient remains in complete remission after 3 years with stable graft function. To our best knowledge, this is the first pediatric case report of a successfully treated stage IV CHL-PTLD after a liver transplant.

KW - Asia

KW - classical HL type PTLD

KW - liver transplant

KW - pediatric

UR - http://www.scopus.com/inward/record.url?scp=85116598921&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000002121

DO - 10.1097/MPH.0000000000002121

M3 - Article

C2 - 33769384

AN - SCOPUS:85116598921

SN - 1077-4114

VL - 43

SP - E1015-E1019

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

IS - 7

ER -

Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this